A prostate cancer test is best taken on a regular basis from the age of forty. A yearly test is generally enough due to the slow growing nature of Prostate cancer. By conducting check ups, the detection of the disease can be completed at a very early stage and needless to say, that the early stage detection might even give complete cure.
John Hopkins Oncology Scientists and researchers have established that the measuring of the chemical process associated with the genetic change triggered by the prostate cancer leads to the detection of early state prostate cancer. Early stage detection ensures complete cure. American Cancer Society however supports routine testing for cancer for only people above 50.
U,K and U..S. scientists are developing a novel prostate cancer test. They collect a sample of prostate fluid, the collection of which takes less than three minutes through a needle inserted inside the body. According to the famous health professionals and doctors Queen's University of Belfaast U.K organic chemistry Heads says: " A convenient and quick method which provides early warning of prostate cancer which will bring relief to many men".
By far, the most popular prostate cancer test, Prostate Specific Antigen test (PSA) is conduced throughout the world. PSA is a protein secreted by prostate gland and abnormally higher values indicate the presence of cancer forming cells. The PSA test is helpful for a Physician in measuring the PSA level in the patient's blood. In conjunction with DRE-digital rectum examination, this test empowers the physician to measure the size of the prostate gland.
Pharmaceuticals Scientists based at Maryland have identified a protein - HAAH enzyme might prove to be a biomarker, the sensitivity and specificity of which is much more accurate than the current methods for cancer detection. This biomarker test will detect cancer very fast and hence will be useful in preventing prostate cancer recurrence.
Swedish medical University Karolinska Institutet scientists have identified risk genes through a simple DNA test and hope that men carrying a known combination of risk genes run 4 to 5 times higher risk of prostate cancer. They say that the risk of prostate cancer recurrence is there even in the cases of unfinished cures.
In the nanoparticle prostate cancer test, golden nanoparticles are first mixed in a solution. Nanoparticles are coaxed to attach themselves to cancer producing proteins. When the patient's drop of blood is dropped in the nano solution, they seek out the protein. If the protein is present, then the golden nanoparticles cluster around it. If there is no cluster formation, the inference is no cancer formation is to be expected
Is being obese, an obstruction for an accurate Prostate cancer test? Texas University Health Science Center in San Antonio, came to the conclusion that in obese men, the sensitivity of PSA testing is being blunted. Doctors believe that obese men produce more estrogen, which drives down testosterone levels and could affect cells that produce antigen in the test.
John Hopkins Oncology Scientists and researchers have established that the measuring of the chemical process associated with the genetic change triggered by the prostate cancer leads to the detection of early state prostate cancer. Early stage detection ensures complete cure. American Cancer Society however supports routine testing for cancer for only people above 50.
U,K and U..S. scientists are developing a novel prostate cancer test. They collect a sample of prostate fluid, the collection of which takes less than three minutes through a needle inserted inside the body. According to the famous health professionals and doctors Queen's University of Belfaast U.K organic chemistry Heads says: " A convenient and quick method which provides early warning of prostate cancer which will bring relief to many men".
By far, the most popular prostate cancer test, Prostate Specific Antigen test (PSA) is conduced throughout the world. PSA is a protein secreted by prostate gland and abnormally higher values indicate the presence of cancer forming cells. The PSA test is helpful for a Physician in measuring the PSA level in the patient's blood. In conjunction with DRE-digital rectum examination, this test empowers the physician to measure the size of the prostate gland.
Pharmaceuticals Scientists based at Maryland have identified a protein - HAAH enzyme might prove to be a biomarker, the sensitivity and specificity of which is much more accurate than the current methods for cancer detection. This biomarker test will detect cancer very fast and hence will be useful in preventing prostate cancer recurrence.
Swedish medical University Karolinska Institutet scientists have identified risk genes through a simple DNA test and hope that men carrying a known combination of risk genes run 4 to 5 times higher risk of prostate cancer. They say that the risk of prostate cancer recurrence is there even in the cases of unfinished cures.
In the nanoparticle prostate cancer test, golden nanoparticles are first mixed in a solution. Nanoparticles are coaxed to attach themselves to cancer producing proteins. When the patient's drop of blood is dropped in the nano solution, they seek out the protein. If the protein is present, then the golden nanoparticles cluster around it. If there is no cluster formation, the inference is no cancer formation is to be expected
Is being obese, an obstruction for an accurate Prostate cancer test? Texas University Health Science Center in San Antonio, came to the conclusion that in obese men, the sensitivity of PSA testing is being blunted. Doctors believe that obese men produce more estrogen, which drives down testosterone levels and could affect cells that produce antigen in the test.
About the Author:
OnProstateCancer.com is the Internet's premier resource for prostate cancer life expectancy, with facts and articles on topics such as treating prostate cancer, and much more. Click the links above for more information !
No comments:
Post a Comment